MMSI

SEC source: 0001415889-24-006977 · form4-03062024_050346.xml · nonDerivative · entry 1

Lloyd Brian G. · CIK 0001671772 · CHIEF LEGAL OFFICER, SECRETARY

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,239

F1 · shares: Represents a grant of restricted stock units ("RSUs"). The RSUs vest in four equal annual installments on each of the first four anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.

SEC source: 0001415889-24-006975 · form4-03062024_050331.xml · nonDerivative · entry 6

LAMPROPOULOS FRED P · CIK 0000901534 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,067,751

F5 · shares: Reflects shares of Common Stock surrendered by the Reporting Person to satisfy tax withholding obligations in connection with the issuance of the performance stock units. These shares were not sold in an open-market transaction.

SEC source: 0001415889-24-006975 · form4-03062024_050331.xml · nonDerivative · entry 5

LAMPROPOULOS FRED P · CIK 0000901534 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,076,094

F4 · shares: These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 3/19/2021.

SEC source: 0001415889-24-006975 · form4-03062024_050331.xml · nonDerivative · entry 4

LAMPROPOULOS FRED P · CIK 0000901534 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,057,132

F3 · shares: Represents a grant of restricted stock units ("RSUs"). The RSUs vest in four equal annual installments on each of the first four anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.

SEC source: 0001415889-24-006973 · form4-03062024_050335.xml · nonDerivative · entry 4

Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,487

F4 · shares: Reflects shares of Common Stock surrendered by the Reporting Person to satisfy tax withholding obligations in connection with the issuance of the performance stock units. These shares were not sold in an open-market transaction.

SEC source: 0001415889-24-006973 · form4-03062024_050335.xml · nonDerivative · entry 3

Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,117

F3 · shares: These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 03/19/2021.

SEC source: 0001415889-24-006973 · form4-03062024_050335.xml · nonDerivative · entry 2

Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,007

F2 · shares: Represents a grant of restricted stock units ("RSUs"). The RSUs vest in four equal annual installments on each of the first four anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.

SEC source: 0001415889-24-001732 · form4-01242024_030158.xml · derivative · entry 3

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires 2024-05-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The acquisition of shares pursuant to an outstanding option and sale of those shares were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan adopted on August 7, 2023.

F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 05/24/2018.

SEC source: 0001415889-24-001732 · form4-01242024_030158.xml · nonDerivative · entry 2

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 29,960

F1 · kind: The acquisition of shares pursuant to an outstanding option and sale of those shares were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan adopted on August 7, 2023.

F2 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.000 to $80.035, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001415889-24-001732 · form4-01242024_030158.xml · nonDerivative · entry 1

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 49,960

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The acquisition of shares pursuant to an outstanding option and sale of those shares were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan adopted on August 7, 2023.

SEC source: 0001415889-23-012784 · form4-08292023_100836.xml · derivative · entry 8

LAMPROPOULOS FRED P · CIK 0000901534 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By spouse

Disclosed balance after: 0

Underlying: Common Stock · 6,000 shares

Expires 2024-04-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Original grant of 10,000 options was to become vested and exercisable in equal annual installments of 20% commencing 4/14/2018. Options not vested as of 6/22/2020 have been forfeited.

F1 · ownership.nature: Represents securities held by the spouse of the Reporting Person. The Reporting Person expressly disclaims beneficial ownership of the securities owned by his spouse.

SEC source: 0001415889-23-012784 · form4-08292023_100836.xml · derivative · entry 7

LAMPROPOULOS FRED P · CIK 0000901534 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 200,000 shares

Expires 2024-04-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 4/14/2018.

SEC source: 0001415889-23-012784 · form4-08292023_100836.xml · nonDerivative · entry 4

LAMPROPOULOS FRED P · CIK 0000901534 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By spouse

Disclosed balance after: 9,228

F3 · kind: The Reporting Person's spouse surrendered 3,660 shares of common stock to the Issuer for payroll taxes and payment of the option price. No shares were sold in the open market.

F1 · ownership.nature: Represents securities held by the spouse of the Reporting Person. The Reporting Person expressly disclaims beneficial ownership of the securities owned by his spouse.

SEC source: 0001415889-23-012784 · form4-08292023_100836.xml · nonDerivative · entry 3

LAMPROPOULOS FRED P · CIK 0000901534 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,032,560

F2 · kind: The Reporting Person surrendered 135,356 shares of common stock to the Issuer for payroll taxes and payment of the option price. No shares were sold in the open market.

SEC source: 0001415889-23-012784 · form4-08292023_100836.xml · nonDerivative · entry 2

LAMPROPOULOS FRED P · CIK 0000901534 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By spouse

Disclosed balance after: 12,888

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.nature: Represents securities held by the spouse of the Reporting Person. The Reporting Person expressly disclaims beneficial ownership of the securities owned by his spouse.

SEC source: 0001415889-23-012784 · form4-08292023_100836.xml · nonDerivative · entry 1

LAMPROPOULOS FRED P · CIK 0000901534 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,167,916

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-23-012529 · form4-08232023_030858.xml · derivative · entry 3

Peterson Neil · CIK 0001926221 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,000 shares

Expires 2024-04-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 4/14/2018.

SEC source: 0001415889-23-012529 · form4-08232023_030858.xml · nonDerivative · entry 2

Peterson Neil · CIK 0001926221 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.79 to $68.05 inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001415889-23-012529 · form4-08232023_030858.xml · nonDerivative · entry 1

Peterson Neil · CIK 0001926221 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-23-012213 · form4-08142023_080805.xml · nonDerivative · entry 1

ANDERSON A SCOTT · CIK 0001184825 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,397

SEC source: 0001415889-23-012152 · form4-08112023_090814.xml · derivative · entry 3

ANDERSON A SCOTT · CIK 0001184825 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2025-06-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 06/07/2019.

SEC source: 0001415889-23-012152 · form4-08112023_090814.xml · nonDerivative · entry 2

ANDERSON A SCOTT · CIK 0001184825 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,217

F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.00 to $69.91 inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001415889-23-012152 · form4-08112023_090814.xml · nonDerivative · entry 1

ANDERSON A SCOTT · CIK 0001184825 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,397

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-23-008544 · form4-05222023_110525.xml · nonDerivative · entry 1

Floyd David · CIK 0001564203 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,500

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 2,262 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 18, 2024. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

F2 · balance_after: Reflects a transfer of 2,914 shares on July 12, 2022 held directly by the reporting person to the David & Lisa Floyd Family LP in a transaction exempt from reporting under Rule 16a-13.

SEC source: 0001415889-23-008484 · form4-05222023_060542.xml · nonDerivative · entry 1

Ward Lynne · CIK 0001786127 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,226

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 2,262 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 18, 2024. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0001415889-23-008483 · form4-05222023_060528.xml · nonDerivative · entry 1

MCDONNELL MICHAEL R · CIK 0001121897 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,312

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 2,262 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 18, 2024. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0001415889-23-008482 · form4-05222023_060549.xml · nonDerivative · entry 1

Carpenter Lonny J · CIK 0001451534 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,784

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 2,262 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 18, 2024. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0001415889-23-008481 · form4-05222023_060501.xml · nonDerivative · entry 1

Gunderson Thomas James · CIK 0001708144 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,414

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 2,262 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 18, 2024. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0001415889-23-008480 · form4-05222023_060512.xml · nonDerivative · entry 1

ANDERSON A SCOTT · CIK 0001184825 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,397

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 2,262 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 18, 2024. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0001415889-23-008479 · form4-05222023_060517.xml · nonDerivative · entry 1

Millner F. Ann · CIK 0001649014 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,960

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 2,262 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 18, 2024. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0001415889-23-008478 · form4-05222023_060516.xml · nonDerivative · entry 1

Evans Stephen C. · CIK 0001844301 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,226

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 2,262 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 18, 2024. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0001415889-23-008662 · form4a-05232023_100541.xml · nonDerivative · entry 1

Floyd David · CIK 0001564203 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,500

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 2,262 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 18, 2024. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

F2 · balance_after: This line in the Form 4, as originally filed on May 22, 2023, incorrectly reported a transfer of 2,914 shares on July 12, 2022 held directly by the reporting person to the David & Lisa Floyd Family LP in a transaction exempt from reporting under Rule 16a-13. This amended Form 4 solely corrects the error, reporting the transfer of 2,914 shares held directly by the reporting person to the David K. Floyd Living Trust in a transaction exempt from reporting under Rule 16a-13.

SEC source: 0001415889-23-008661 · form4-05232023_100505.xml · nonDerivative · entry 1

Kaiser Laura S. · CIK 0001726511 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,312

F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 2,262 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 18, 2024. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

SEC source: 0001415889-23-005224 · form4-03202023_080326.xml · derivative · entry 3

Peterson Neil · CIK 0001926221 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Common Stock · 8,000 shares

Expires 2024-04-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 4/14/2018.

SEC source: 0001415889-23-005224 · form4-03202023_080326.xml · nonDerivative · entry 2

Peterson Neil · CIK 0001926221 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

SEC source: 0001415889-23-005224 · form4-03202023_080326.xml · nonDerivative · entry 1

Peterson Neil · CIK 0001926221 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-23-004931 · form4-03152023_050357.xml · nonDerivative · entry 1

Voigt Michel James · CIK 0001836958 · CHIEF HUMAN RESOURCES OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 515

SEC source: 0001415889-23-005032 · form4-03162023_100346.xml · nonDerivative · entry 2

LAMPROPOULOS FRED P · CIK 0000901534 · Director · PRESIDENT AND CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 967,916

F2 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.00 to $68.75 inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001415889-23-005032 · form4-03162023_100346.xml · nonDerivative · entry 1

LAMPROPOULOS FRED P · CIK 0000901534 · Director · PRESIDENT AND CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 987,615

F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.00 to $67.99 inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001415889-23-004830 · form4-03142023_060302.xml · nonDerivative · entry 1

Lloyd Brian G. · CIK 0001671772 · CHIEF LEGAL OFFICER, SECRETARY

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,920

SEC source: 0001415889-23-004692 · form4-03102023_110336.xml · derivative · entry 3

Ward Lynne · CIK 0001786127 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,433

Underlying: Common Stock · 2,000 shares

Expires 2026-08-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 33% commencing 08/28/2020.

SEC source: 0001415889-23-004692 · form4-03102023_110336.xml · nonDerivative · entry 2

Ward Lynne · CIK 0001786127 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,964

F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.51 to $66.86, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001415889-23-004692 · form4-03102023_110336.xml · nonDerivative · entry 1

Ward Lynne · CIK 0001786127 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,549

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-23-004473 · form4-03082023_050345.xml · nonDerivative · entry 4

ANDERSON A SCOTT · CIK 0001184825 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,135

SEC source: 0001415889-23-004473 · form4-03082023_050345.xml · derivative · entry 6

ANDERSON A SCOTT · CIK 0001184825 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2024-05-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 05/24/2018.

SEC source: 0001415889-23-004473 · form4-03082023_050345.xml · derivative · entry 5

ANDERSON A SCOTT · CIK 0001184825 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · Not disclosed shares

Expires 2023-05-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 05/26/2017.

SEC source: 0001415889-23-004473 · form4-03082023_050345.xml · nonDerivative · entry 3

ANDERSON A SCOTT · CIK 0001184825 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,135

F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.20 to $67.00 inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001415889-23-004473 · form4-03082023_050345.xml · nonDerivative · entry 2

ANDERSON A SCOTT · CIK 0001184825 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,135

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-23-004473 · form4-03082023_050345.xml · nonDerivative · entry 1

ANDERSON A SCOTT · CIK 0001184825 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,135

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-23-004387 · form4-03072023_080348.xml · nonDerivative · entry 1

Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,688